Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-02-13Clinical Trial Update: Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study [NA]
The update describes a study comparing computer-assisted hair implantation using the ARTAS System to manual implantation for androgenetic al…
-
CLINICAL_TRIALS withdrawal · 2017-01-24Clinical Trial Update: Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil [NA]
The trial NCT02486848 evaluating the dose response of minoxidil in women identified as non-responders to 5% topical minoxidil has been withd…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia [Phase 4]
Phase 4 clinical trial update evaluating different platelet-rich plasma regimens for androgenetic alopecia.
-
FDA approval · 2017-01-06FDA Approved: FINASTERIDE — Original Application (Ascend Laboratories, LLC)
The FDA approved the original Abbreviated New Drug Application for finasteride by Ascend Laboratories, LLC, enabling a generic version of Fi…
-
FDA approval · 2017-01-05FDA Approved: FINASTERIDE — Original Application (Ascend Laboratories, LLC)
FDA approved Finasteride under an Original Application for Ascend Laboratories, LLC (ANDA 204304), marking the approval of a generic version…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-12-02Clinical Trial Update: Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO [Phase 2]
An update on a Phase 2 clinical trial evaluating the Theradome LH80 PRO device for treating androgenetic alopecia in men.
-
CLINICAL_TRIALS research · 2016-12-01Clinical Trial Update: Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) [NA]
This clinical trial update concerns Hairstetics Anchoring System for female pattern hair loss, with the current trial status listed as unkno…
-
FDA approval · 2016-11-22FDA Approved: FINASTERIDE — Supplemental Application (Dr Reddys Laboratories Inc)
The FDA approved a supplemental application for Finasteride from Dr Reddys Laboratories Inc, updating the status of a generic Finasteride pr…
-
FDA approval · 2016-11-13FDA Approved: HAIR REGROWTH TREATMENT — Supplemental Application (CVS Pharmacy)
The FDA approved a supplemental application for a hair regrowth treatment using minoxidil, submitted by CVS Pharmacy.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia [Phase 1]
This Phase 1 trial assesses the local pharmacokinetics and tolerability of applying bimatoprost to the scalp in men with androgenetic alopec…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss [Phase 3]
Phase 3 clinical trial update evaluating the effectiveness and safety of 5% minoxidil topical foam for male pattern hair loss (androgenetic …
-
CLINICAL_TRIALS withdrawal · 2016-09-02Clinical Trial Update: The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia [Phase 4]
Phase 4 trial evaluating finasteride vs spironolactone and topical minoxidil for postmenopausal female androgenetic alopecia has been withdr…
-
FDA approval · 2016-07-21FDA Approved: OPUSMEDS EXTRA STRENGTH MINOXIDIL — Supplemental Application (Opus Meds LLC)
The FDA approved a supplemental application for Opus Meds LLC to introduce Opus Meds Extra Strength Minoxidil (minoxidil 5%) as a new streng…
-
FDA approval · 2016-07-21FDA Approved: SANTO REMEDIO MENS HAIR REGROWTH TREATMENT MINOXIDIL TOPICAL SOLUTION EXTRA STRENGTH UNSCENTED — Supplemental Application (SANTO REMEDIO LLC)
FDA approved a supplemental application for Santo Remedio LLC's Minoxidil topical solution extra-strength unscented for men's hair regrowth.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Treatment of Androgenetic Alopecia in Males and Females [NA]
A clinical trial evaluating a treatment for androgenetic alopecia in men and women has completed.
-
FDA approval · 2016-05-24FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Women's Rogaine Unscented containing minoxidil submitted by Kenvue Brands LLC.
-
FDA approval · 2016-03-30FDA Approved: HAIR REGROWTH TREATMENT — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for a CVS Pharmacy hair regrowth treatment containing minoxidil (5% minoxidil) for androgenetic alop…
-
FDA approval · 2016-02-25FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Finasteride from Aurobindo Pharma Limited, enabling a generic Finasteride product.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females [NA]
Completed clinical trial evaluating a cosmetic lotion for androgenetic alopecia in men and women; results were posted in 2016.
-
FDA approval · 2016-01-11FDA Approved: PROPECIA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROPECIA (finasteride) submitted by Organon LLC.
-
FDA approval · 2015-12-23FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited, authorizing the generic finasteride product to be…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) [Phase 2]
Phase 2 safety and efficacy study of bimatoprost in men with androgenetic alopecia (AGA) completed, with results posted in 2015.
-
FDA approval · 2015-07-06FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application [Phase 1, Phase 2]
The Phase 1/2 trial evaluating the topical DA-4001 for androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy [NA]
A completed clinical trial assessed low level laser therapy as a treatment for female androgenetic alopecia, with results posted in 2015.